IMS Health to acquire competitor SDI Health

Share this article:
IMS Health said it signed a definitive agreement to acquire privately held insight and analytics company SDI Health, bringing together two of the largest pharmaceutical marketing research firms. Financial terms of the deal were not disclosed.
Both companies declined to discuss the acquisition beyond a joint statement released last month. Unnamed company sources told Ed Silverman, who first reported the deal on his Pharmalot blog, that as much as 15% of SDI staff could lose their jobs as a result of the acquisition.
Like IMS, SDI provides prescription data. It also tracks a robust set of promotional information, including pharma company spending on detailing, meetings and events and ePromotion activities.
“The acquisition will enable more robust patient and specialty analytics, and will give IMS the ability to provide a broader set of stakeholders with clinically rich insights from all healthcare channels, including hospitals, providers and pharmacies,” the joint statement said. “The addition of SDI's complementary information assets and capabilities positions IMS to improve existing offerings, fuel new investments and deliver greater innovation and value to a healthcare industry that is seeking to drive increased efficiencies as a result of significant, ongoing pressure to reduce costs and expand patient access.”
Gary Gatyas, an IMS Health spokesperson, declined to speculate on timing for the completion of the deal, citing pre-merger notification requirements with respect to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets